Isomorphic Labs

The page features products from Google Cloud, Google Maps Platform, and others for developers and enterprises.

Google Cloud offers cloud and AI services for healthcare research and patient experience.

Find all the latest news about Google Cloud and Machine Learning & AI with customer stories, product announcements, solutions and more.

News, updates, and best practices for managing APIs on Google Cloud.

News, updates, and best practices for developing apps on Google Cloud Platform.

Faster and more secure software development through proven DevOps practices and an open-source-based application platform.

Isomorphic Labs aims to reimagine drug discovery using AI.

The company is recruiting a diverse, inclusive and multidisciplinary team.

Google Cloud is using Gemini-powered AI agents to transform healthcare from manual, siloed data entry into a proactive, automated, and patient-centered experience.

Bev is the Chief People Officer and has experience in interdisciplinary working.

Ben is the Chief Medical Officer with nearly 20 years of biopharmaceutical experience, including expertise in precision oncology and advancing therapeutic programs from discovery through regulatory approval.

Max Jaderberg is President at Isomorphic Labs. In his previous role of Chief AI Officer he led the research, development, and application of breakthrough AI models for drug design such as AlphaFold 3. He was part of the founding team of Isomorphic Labs.

Google Cloud's sales team discusses pricing, custom solutions, and purchasing options for organizations.

Google offers AI and cloud computing services, including security, data management, and hybrid and multicloud services.

Isomorphic Labs is building a future where frontier AI can help to unlock deeper scientific insights, faster breakthroughs, and life-changing medicines.

Isomorphic Labs Limited’s agreement sets out terms for using isomorphiclabs.com, including intellectual property rights, termination, external links, governing law and changes to the agreement.

OpenAI tells investors it has $18 billion less revenue than the $68 billion figure it reported the previous month, prompting declines in shares of Nvidia, CoreWeave, Oracle and Nebius. The roundup notes growing investor scrutiny of AI revenue expectations even as Google launches an autonomous Gemini assistant and companies release new models. It also highlights large quantum-computing fundraises and a federal bar on Microsoft and other firms sponsoring employee green-card applications.

Oct 2026 · SiliconANGLENews article

Alphabet spinoff Isomorphic Labs is reportedly raising a funding round at a proposed valuation of $40 billion to $50 billion. Its IsoDDE platform automates parts of drug discovery, and the company says it outperforms AlphaFold on binding-pocket and molecular-interaction tasks. Isomorphic earns revenue through drugmaker research partnerships, including deals with Eli Lilly, Novartis and Johnson & Johnson.

Oct 2026 · SiliconANGLENews article

Isomorphic Labs, an AI-powered drug discovery startup spun out of Google DeepMind, is in early talks to raise new funding at a valuation of at least $40 billion.

Oct 2026 · Bloomberg TechNews article

A consortium of U.S. government agencies, technology companies and research groups commits $1.8 billion to build biology datasets for AI models. The Department of Energy contributes more than $500 million over five years, while Biohub commits $400 million to research and external projects, including collecting cell data with microscopy. NIH provides access to existing datasets, and Google DeepMind, Isomorphic Labs and Meta contribute $300 million together.

Oct 2026 · SiliconANGLENews article